Skye Bioscience, Inc. SKYE
1.67
(0.03)
(1.76%)
as of 25 Sep
- Market cap
- $7.5M
- P/E
- 0.0×
Follow SKYE
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
3.30 | 16.32 | 0.84 | 0.74 | 2.46 | 3.38 | 2.05 | 0.12 | 0.69 | 0.42 |
Net Debt/EBITDA |
0.45 | 2.34 | 0.17 | (0.03) | 1.03 | 0.27 | 0.24 | 0.11 | 0.01 | 0.02 |
Debt/Assets |
0.00% | 0.00% | 36.62% | 20.29% | 15.47% | 34.85% | 19.39% | 69.54% | 42.18% | 0.00% |
Debt/Equity |
0.00 | 0.00 | (2.05) | (0.61) | 0.26 | 2.07 | 0.71 | (0.09) | (0.29) | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.77 | 0.95 | 0.37 | 0.65 | 0.76 | 0.92 | (5.73) | 0.21 | 0.81 | 1.01 |
Capex/Depreciation |
0.49 | (0.27) | 12.16 | (0.05) | (0.14) | (0.01) | 0.00 | (0.07) | (0.52) | (0.17) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (126.85%) | (80.48%) | 1,464.81% | (1,364.21%) | (269.90%) | (1,313.58%) | (14.01%) | 200.65% | 127.65% | 184.06% | |
| (110.66%) | (62.73%) | (357.64%) | (205.43%) | (136.06%) | (281.07%) | 53.20% | (1,526.80%) | (939.88%) | (182.72%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(282.63%) | (39.11%) | 1,705.78% | 630.98% | (147.25%) | (348.14%) | 102.51% | 137.28% | 1,663.30% | 939.42% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(8.61) | (5.59) | (9.63) | (46.01) | (32.30) | (52.52) | (89.17) | (65.14) | (239.36) | (375.16) |
Cash per Share |
5.19 | 15.00 | 11.80 | 4.50 | 44.21 | 21.44 | 27.14 | 30.66 | 18.89 | 10.77 |
Shareholders Equity per Share |
4.04 | 14.94 | (2.43) | (10.84) | 28.85 | 3.91 | 8.11 | (256.80) | (57.15) | (152.73) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.04 | 14.94 | (2.43) | (10.84) | 28.85 | 3.91 | 8.11 | (256.80) | (57.15) | (152.73) |
Free Cash Flow |
(42.71) | (25.48) | (8.43) | (12.77) | (6.57) | (6.06) | (6.03) | (3.95) | (3.35) | (3.56) |
Working Capital |
18.89 | 66.49 | (2.25) | (3.18) | 5.70 | 1.88 | 1.02 | (13.99) | (0.25) | (0.38) |
Capital Expenditures |
0.35 | (0.25) | 5.52 | (0.03) | (0.09) | (0.01) | — | 0.00 | (0.02) | (0.01) |
Net Current Asset Value |
18.80 | 66.22 | (2.42) | (3.18) | 5.62 | 0.44 | 0.55 | (15.57) | (0.80) | (1.49) |
| Other line items | ||||||||||
Quick Ratio |
3.14 | 15.77 | 0.74 | 0.10 | 2.30 | 3.14 | 1.89 | 0.12 | 0.33 | 0.15 |
Depreciation/Fixed assets |
0.80 | 0.63 | 10.49 | 6.88 | 7.16 | 74.78 | 315.40 | 17.68 | 27.14 | 6.93 |
Cash ROIC |
(96.07%) | (19.53%) | (111.28%) | (14,353.47%) | (40.07%) | (157.20%) | (217.71%) | 31.97% | 1,108.31% | 264.16% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(8.69) | (5.53) | (15.93) | (45.91) | (31.85) | (52.46) | (89.17) | (65.07) | (237.95) | (373.99) |
Capex per Share |
0.07 | (0.05) | 6.30 | (0.10) | (0.45) | (0.06) | 0.00 | (0.07) | (1.41) | (1.17) |
Average Payables |
1.30 | 0.76 | 1.38 | 1.35 | 0.64 | 0.26 | 0.08 | 0.06 | 0.19 | 0.20 |
Average Assets |
50.54 | 42.35 | 10.53 | 9.48 | 6.26 | 2.33 | 1.98 | 1.26 | 0.44 | 1.92 |
Average Common Equity |
44.09 | 33.01 | (2.57) | 1.43 | 3.16 | 0.50 | (7.51) | (9.57) | (3.24) | (1.90) |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates